Clinical News: Page 3321

Vital Images, Mirada Solutions close deal
By AuntMinnie.com staff writers
Three-dimensional-software developer Vital Images and fusion software firm Mirada Solutions have signed an agreement to integrate Mirada’s PET image fusion application into Vital Images’ Vitrea 2 3-D software product
September 3, 2003
JNM names Schelbert editor-in-chief
By AuntMinnie.com staff writers
The Journal of Nuclear Medicine has appointed Dr. Heinrich Schelbert as its editor-in-chief.
September 3, 2003
Fonar reports summer sales exceeding $19 million
By AuntMinnie.com staff writers
MRI vendor Fonar said it has received $19.6 million in revenues from the sale of 14 of its Stand-Up MRI units in June, July, and August.
September 3, 2003
Cytogen names Schnittker as CFO
By AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen has selected Christopher Schnittker as its chief financial officer (CFO).
September 3, 2003
Speedy PET/CT exam showcased at 2003 SNM meeting
By Jonathan S. Batchelor
A protocol for conducting fast PET/CT was the hot topic at the 2003 Society of Nuclear Medicine (SNM) meeting in New Orleans, and was selected by the society as its image of the year.
September 2, 2003
EC greenlights GE-Instrumentarium deal
By AuntMinnie.com staff writers
The European Commission has cleared GE Medical Systems’ proposed acquisition of Finnish firm Instrumentarium, subject to conditions relating to Instrumentarium’s patient-monitoring operations.
September 2, 2003
RITA debuts StarBurst Semi-Flex
By AuntMinnie.com staff writers
Radiofrequency ablation developer RITA Medical Systems has debuted StarBurst Semi-Flex, a flexible RF ablation device targeted at the interventional radiology market.
September 2, 2003
flexScan, Alliance Imaging team up
By AuntMinnie.com staff writers
Whole-body CT services provider flexScan of Mission Viejo, CA, has named imaging services firm Alliance Imaging as its exclusive imaging center provider.
September 2, 2003
Dow and Avidex to partner on radiopharmaceuticals
By AuntMinnie.com staff writers
Avidex Limited, a Milton Park, U.K.-based biotechnology company, and Dow Chemical have agreed to collaborate in the creation of biotargeted radiopharmaceuticals for cancer treatment.
September 2, 2003
Radiocontrast-induced nephropathy poses serious risk in patients, study shows
By Paula Moyer
In a study presented at the 2003 American Society of Health-System Pharmacists in San Diego, researchers looked for an association between patient risk factors and RCIN -- particularly diabetes, chronic heart failure, and advanced age -- and administration of a radiocontrast agent within 48 hours prior to cardiac catheterization.
September 2, 2003
RIS/PACS Webcast goes live September 3
By Brian Casey
For insight into the great mysteries of RIS/PACS integration, check out a live Webcast presentation on the topic this Wednesday, September 3, from 11 a.m.-12 p.m. PDT.
September 2, 2003
Guidant acquires bioabsorbable polymers
By AuntMinnie.com staff writers
Interventional firm Guidant has acquired the right to use bioabsorbable polymer technologies specifically designed for vascular use by MediVas.
September 1, 2003
Previous Page
Page 3321 of 3667
Next Page